Electrophysiology Signal Articles & Analysis

1 news found

STALICLA completes successful phase 1b trials for the first precision medicine in autism spectrum disorder

In addition to showing good safety and tolerability profiles, and dose-dependent target engagement, STP1 treatment resulted in positive signals in clinical markers of neurological and behavioral function, including improved processing speed and crystallized cognition composite. ...

Mar. 24, 2022

BySTALICLA

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you